Transcatheter arterial chemoembolization plus donafenib and sintilimab for unresectable hepatocellular carcinoma: A prospective, single-arm, phase II study.
Year: 2025
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institutions: Nanfang Hospital, Southern Medical University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814563
